[ORGANIZATION]
Polpharma
Featured in 2 tracked stories · first seen
Situations
Poland pharmaceutical industry and reimbursement
3 clusters · 5 sources · last updated
Latest: Poland introduces reforms to drug reimbursement and medical device access
The pharmaceutical landscape in Poland involves complex regulatory and financial processes. The reimbursement of medications is determined through multi-stage assessments by authorities such as the Agency for Health Tech
Pharmaceutical impurity recalls in Poland
2 clusters · 5 sources · last updated
Latest: Polish regulators reject Polpharma application and withdraw Dutilox from market
Polish pharmaceutical regulators have initiated several actions involving the recall and withdrawal of medications due to the presence of nitrosamine impurities, which are potentially carcinogenic. Initially, the Chief